• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Evaluating Sonida Senior Living (SNDA) Valuation After Strong 1 Year Return And Premium P/S Multiple

    Simply Wall St·03/14/2026 07:33:07
    Listen to the news

    Why Sonida Senior Living Is On Investors’ Radar

    Sonida Senior Living (SNDA) has drawn attention after recent share price swings, with a 1 day return of 4.34% contrasting with a 4.28% decline over the past week. This has prompted closer portfolio reviews.

    See our latest analysis for Sonida Senior Living.

    That sharp 1 day share price return of 4.34% comes after a softer 7 day share price return of 4.28%. Sonida Senior Living still has a 90 day share price return of 13.06% and a 1 year total shareholder return of 48.79%, suggesting momentum has held up over a longer stretch despite recent volatility.

    If you are looking beyond senior living and want to see what else is moving, our screener of 33 healthcare AI stocks is a useful place to start comparing opportunities.

    With Sonida posting a 1 year total return of 48.79% but trading about 10% above its US$31.50 analyst target, the key question is whether the market is stretched here or simply recognizing future growth early.

    Preferred Price-to-Sales Multiple of 4.9x: Is It Justified?

    On a simple P/S basis, Sonida Senior Living looks expensive, with a 4.9x multiple at a last close of $35.07 compared with both peers and the broader US Healthcare sector. For investors, the question is whether that premium reflects confidence in the business model or if expectations have simply run ahead of the fundamentals.

    The P/S ratio compares the total market value of the company to its revenue, so it is often used when a company is unprofitable, as Sonida currently is. With revenue of about $336.4m and a reported net loss of $76.4m, the focus naturally shifts to what investors are willing to pay for each dollar of sales rather than earnings that are still in negative territory.

    Here, the gap is wide. Management has reduced losses over the past 5 years at an annual rate of 19.8% and revenue is forecast to grow by 5.3% per year. Yet the 4.9x P/S is described as expensive versus the US Healthcare industry average of 1.2x and a peer average of 0.5x. Compared with an estimated fair P/S of 0.6x, the current multiple sits well above the level the market could move toward if sentiment cooled or if revenue trends do not support such a rich sales valuation.

    Explore the SWS fair ratio for Sonida Senior Living

    Result: Price-to-Sales of 4.9x (OVERVALUED)

    However, that premium P/S and a recent net loss of US$76.4m could be pressured further if revenue growth stalls or if sector sentiment toward senior housing cools.

    Find out about the key risks to this Sonida Senior Living narrative.

    Next Steps

    If this feels like a mixed picture, it is worth checking the underlying data yourself and deciding how comfortable you are with the trade off. To frame that decision, have a look at the 1 important warning sign we have identified that investors are watching closely.

    Looking for more investment ideas?

    If this stock has sharpened your focus, do not stop here. Use the Simply Wall Street Screener to line up your next set of ideas with confidence.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.